Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80e9eee1d296c7be7c0ef85500eb05ca |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate |
2018-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca265dca30f93bb01542f1d729e59a72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07745d7986d4fd8bbd7d4b4a88690be4 |
publicationDate |
2019-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10414721-B1 |
titleOfInvention |
Inhibitor of endocannabinoid cellular reuptake |
abstract |
Provided is a highly potent and selective endocannabioid cellular reuptake inhibitor represented by formula (I): n nor a pharmaceutically acceptable solvate or co-crystal thereof as well as to a formulation comprising this inhibitor, and to methods of treatment in which this inhibitor is used. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115919824-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115919824-A |
priorityDate |
2018-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |